242 related articles for article (PubMed ID: 29794970)
1. Application of CRISPR/Cas9 Gene Editing System on MDV-1 Genome for the Study of Gene Function.
Zhang Y; Tang N; Sadigh Y; Baigent S; Shen Z; Nair V; Yao Y
Viruses; 2018 May; 10(6):. PubMed ID: 29794970
[TBL] [Abstract][Full Text] [Related]
2. V5 and GFP Tagging of Viral Gene pp38 of Marek's Disease Vaccine Strain CVI988 Using CRISPR/Cas9 Editing.
Li W; Zhang Y; Moffat K; Nair V; Yao Y
Viruses; 2022 Feb; 14(2):. PubMed ID: 35216029
[TBL] [Abstract][Full Text] [Related]
3. Targeted Editing of the
Zhang Y; Luo J; Tang N; Teng M; Reddy VRAP; Moffat K; Shen Z; Nair V; Yao Y
Viruses; 2019 Apr; 11(5):. PubMed ID: 31027375
[TBL] [Abstract][Full Text] [Related]
4. Characterization of a very virulent Marek's disease virus mutant expressing the pp38 protein from the serotype 1 vaccine strain CVI988/Rispens.
Lee LF; Cui X; Cui Z; Gimeno I; Lupiani B; Reddy SM
Virus Genes; 2005 Aug; 31(1):73-80. PubMed ID: 15965611
[TBL] [Abstract][Full Text] [Related]
5. Marek's disease virus as a CRISPR/Cas9 delivery system to defend against avian leukosis virus infection in chickens.
Liu Y; Xu Z; Zhang Y; Yu M; Wang S; Gao Y; Liu C; Zhang Y; Gao L; Qi X; Cui H; Pan Q; Li K; Wang X
Vet Microbiol; 2020 Mar; 242():108589. PubMed ID: 32122593
[TBL] [Abstract][Full Text] [Related]
6. Efficient Cross-Screening and Characterization of Monoclonal Antibodies against Marek's Disease Specific Meq Oncoprotein Using CRISPR/Cas9-Gene-Edited Viruses.
Teng M; Liu JL; Luo Q; Zheng LP; Yao Y; Nair V; Zhang GP; Luo J
Viruses; 2023 Mar; 15(4):. PubMed ID: 37112797
[TBL] [Abstract][Full Text] [Related]
7. A deletion in the glycoprotein L (gL) gene of U.S. Marek's disease virus (MDV) field strains is insufficient to confer increased pathogenicity to the bacterial artificial chromosome (BAC)-based strain, RB-1B.
Shaikh SA; Katneni UK; Dong H; Gaddamanugu S; Tavlarides-Hontz P; Jarosinski KW; Osterrieder N; Parcells MS
Avian Dis; 2013 Jun; 57(2 Suppl):509-18. PubMed ID: 23901769
[TBL] [Abstract][Full Text] [Related]
8. Comparative analysis of oncogenic genes revealed unique evolutionary features of field Marek's disease virus prevalent in recent years in China.
Tian M; Zhao Y; Lin Y; Zou N; Liu C; Liu P; Cao S; Wen X; Huang Y
Virol J; 2011 Mar; 8():121. PubMed ID: 21406076
[TBL] [Abstract][Full Text] [Related]
9. Fully Attenuated
Sun A; Zhao X; Zhu X; Kong Z; Liao Y; Teng M; Yao Y; Luo J; Nair V; Zhuang G; Zhang G
Microbiol Spectr; 2022 Dec; 10(6):e0287122. PubMed ID: 36350141
[TBL] [Abstract][Full Text] [Related]
10. Targeted Deletion of Glycoprotein B Gene by CRISPR/Cas9 Nuclease Inhibits
Zhang Y; Li W; Tang N; Moffat K; Nair V; Yao Y
J Virol; 2022 Mar; 96(6):e0202721. PubMed ID: 35107377
[TBL] [Abstract][Full Text] [Related]
11. Comparative analysis of Marek's disease virus (MDV) glycoprotein-, lytic antigen pp38- and transformation antigen Meq-encoding genes: association of meq mutations with MDVs of high virulence.
Shamblin CE; Greene N; Arumugaswami V; Dienglewicz RL; Parcells MS
Vet Microbiol; 2004 Sep; 102(3-4):147-67. PubMed ID: 15327791
[TBL] [Abstract][Full Text] [Related]
12. Recombinant Marek's disease virus type 1 provides full protection against very virulent Marek's and infectious bursal disease viruses in chickens.
Li K; Liu Y; Liu C; Gao L; Zhang Y; Cui H; Gao Y; Qi X; Zhong L; Wang X
Sci Rep; 2016 Dec; 6():39263. PubMed ID: 27982090
[TBL] [Abstract][Full Text] [Related]
13. Protective efficacy of a recombinant bacterial artificial chromosome clone of a very virulent Marek's disease virus containing a reticuloendotheliosis virus long terminal repeat.
Mays JK; Black-Pyrkosz A; Spatz S; Fadly AM; Dunn JR
Avian Pathol; 2016 Dec; 45(6):657-666. PubMed ID: 27258614
[TBL] [Abstract][Full Text] [Related]
14. Properties of a meq-deleted rmd5 Marek's disease vaccine: protection against virulent MDV challenge and induction of lymphoid organ atrophy are simultaneously attenuated by serial passage in vitro.
Lee LF; Kreager K; Heidari M; Zhang H; Lupiani B; Reddy SM; Fadly A
Avian Dis; 2013 Jun; 57(2 Suppl):491-7. PubMed ID: 23901766
[TBL] [Abstract][Full Text] [Related]
15. [Comparison of immunoprotection between vaccination with meq-deleted Marek's disease virus and vaccine strain CVI988/Rispens].
Duan L; Su S; Wang Y; Li S; Sun P; Chen W; Cui Z
Wei Sheng Wu Xue Bao; 2014 Nov; 54(11):1353-61. PubMed ID: 25752142
[TBL] [Abstract][Full Text] [Related]
16. Genetic interference exerted by Salmonella-delivered CRISPR/Cas9 significantly reduces the pathological burden caused by Marek's disease virus in chickens.
Senevirathne A; Hewawaduge C; Lee JH
Vet Res; 2021 Sep; 52(1):125. PubMed ID: 34593043
[TBL] [Abstract][Full Text] [Related]
17. Differential amplification of Marek's disease CVI988 vaccine and of wild-type isolates from organs of commercial chickens using single or duplexed probes in real-time PCR.
Davidson I; Natour-Altoury A; Raibstein I; Dahan Y
Avian Pathol; 2017 Dec; 46(6):610-614. PubMed ID: 28532188
[TBL] [Abstract][Full Text] [Related]
18. A Common Live-Attenuated Avian Herpesvirus Vaccine Expresses a Very Potent Oncogene.
Conradie AM; Bertzbach LD; Bhandari N; Parcells M; Kaufer BB
mSphere; 2019 Oct; 4(5):. PubMed ID: 31597721
[TBL] [Abstract][Full Text] [Related]
19. The detection of the meq gene in chicken infected with Marek's disease virus serotype 1.
Chang KS; Lee SI; Ohashi K; Ibrahim A; Onuma M
J Vet Med Sci; 2002 May; 64(5):413-7. PubMed ID: 12069073
[TBL] [Abstract][Full Text] [Related]
20. Circulating hypervirulent Marek's disease viruses in vaccinated chicken flocks in Taiwan by genetic analysis of meq oncogene.
Cheng MC; Lai GH; Tsai YL; Lien YY
PLoS One; 2024; 19(5):e0303371. PubMed ID: 38728352
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
